When kidney stone disease is diagnosed in a patient who must remain on antithrombotic therapy due to a high risk of thrombotic complications, standard stone intervention may require modification or deferral. This scenario requires a protocol tailored specifically to this high-risk population.
The patient is on antithrombotic therapy that cannot be safely discontinued and is at high risk of thrombotic complications. Stone intervention options are constrained and must be carefully considered in this context.
For eligible patients in this setting, a conservative observational strategy may be appropriate as an initial step — particularly when the stone is not causing acute symptoms. The full protocol specifies the exact criteria, decision points, and structured pathway.